GSK PLC DRNGSK PLC DRNGSK PLC DRN

GSK PLC DRN

No trades
See on Supercharts

G1SK34 bonds

Below is the list of GSK PLC DRN corporate bonds. Investors often opt for a company's bonds for their increased stability in times of market volatility. Study prices, yields, and other stats and find a reliable investment.
Symbol
YTM %
Volume
Price %
Coupon %
Maturity date
Outstanding amt
Face value
Min denom amt
Issuer
GGSK3981911GlaxoSmithKline Capital, Inc. 4.2% 18-MAR-2043
6.40%810 K81.67%4.20%2043-03-18500 M USD1,000.00 USD2,000.00 USDGlaxoSmithKline Capital, Inc.
XXS217060907GLAXOSM.CAP. MTN 20/35MTN
6.35%070.99%1.63%2035-05-12750 M GBP1,000.00 GBP100,000.00 GBPGlaxoSmithKline Capital Plc
GGSK4632357GlaxoSmithKline Capital, Inc. 3.625% 15-MAY-2025
6.13%64 K99.84%3.63%2025-05-151 B USD1,000.00 USD2,000.00 USDGlaxoSmithKline Capital, Inc.
883GIGLAXOSMITHKLINE CAPITAL PLC 5.25% GTD SNR EMTN 10/04/20426.08%093.05%5.25%2042-04-10477.82 M GBP1,000.00 GBP50,000.00 GBPGlaxoSmithKline Capital Plc
117RIGLAXOSMITHKLINE CAPITAL PLC 4.25% GTD SNR EMTN 18/12/456.06%8.46 K82.51%4.25%2045-12-18370.79 M GBP1,000.00 GBP100,000.00 GBPGlaxoSmithKline Capital Plc
771ZCGLAXOSMITHKLINE CAPITAL PLC 6.375% GTD SNR EMTN 09/03/395.62%0105.88%6.38%2039-03-09631.3 M GBP1,000.00 GBP50,000.00 GBPGlaxoSmithKline Capital Plc
GGSK.GJGlaxoSmithKline Capital, Inc. 6.375% 15-MAY-2038
5.35%2.11 M107.87%6.38%2038-05-152.75 B USD1,000.00 USD2,000.00 USDGlaxoSmithKline Capital, Inc.
GGSK6023693GlaxoSmithKline Capital, Inc. 4.875% 15-APR-2035
5.25%1.08 M97.52%4.88%2035-04-15750 M USD1,000.00 USD2,000.00 USDGlaxoSmithKline Capital, Inc.
GGSK6023692GlaxoSmithKline Capital Plc FRN 12-MAR-2027
5.12%400 K99.52%4.85%2027-03-12600 M USD1,000.00 USD2,000.00 USDGlaxoSmithKline Capital Plc
AAG99GLAXOSMITHKLINE CAPITAL PLC 5.25% GTD SNR EMTN 19/12/20334.85%0102.45%5.25%2033-12-19574.17 M GBP1,000.00 GBP1,000.00 GBPGlaxoSmithKline Capital Plc
UUS377373AH8GLAXOSM.CAP. 19/29
4.73%095.35%3.38%2029-06-011 B USD1,000.00 USD2,000.00 USDGlaxoSmithKline Capital Plc
GGSK6023695GlaxoSmithKline Capital, Inc. 4.5% 15-APR-2030
4.66%16.41 M99.37%4.50%2030-04-15850 M USD1,000.00 USD2,000.00 USDGlaxoSmithKline Capital, Inc.
772WIGLAXOSMITHKLINE CAPITAL INC 5.375% GTD SNR NTS 15/04/20344.57%0105.28%5.38%2034-04-15500 M USD1,000.00 USD1,000.00 USDGlaxoSmithKline Capital, Inc.
XXS217060184GLAXOSM.CAP. MTN 20/28MTN
4.44%090.38%1.25%2028-10-12750 M GBP1,000.00 GBP100,000.00 GBPGlaxoSmithKline Capital Plc
UUS377372AN7GLAXOSMITHKLINE CAP.18/28
4.42%098.53%3.88%2028-05-151.75 B USD1,000.00 USD2,000.00 USDGlaxoSmithKline Capital, Inc.
GGSK6023691GlaxoSmithKline Capital Plc 4.315% 12-MAR-2027
4.00%5.04 M100.55%4.32%2027-03-12400 M USD1,000.00 USD2,000.00 USDGlaxoSmithKline Capital Plc
XXS293369275GSK CAP B.V. 24/36 MTN
3.62%096.98%3.25%2036-11-19600 M EUR1,000.00 EUR100,000.00 EURGSK Capital BV
XXS255381776GSK CAP B.V. 22/32 MTN
3.20%099.55%3.13%2032-11-28700 M EUR1,000.00 EUR100,000.00 EURGSK Capital BV
XXS293369143GSK CAP B.V. 24/31 MTN
3.00%099.34%2.88%2031-11-19700 M EUR1,000.00 EUR100,000.00 EURGSK Capital BV
XXS182282979GLAXOSM.CAP. MTN 18/30MTN
2.83%095.21%1.75%2030-05-21750 M EUR1,000.00 EUR100,000.00 EURGlaxoSmithKline Capital Plc
XXS168152035GLAXOSM.CAP. MTN 17/29
2.64%095.03%1.38%2029-09-12500 M EUR1,000.00 EUR100,000.00 EURGlaxoSmithKline Capital Plc
GGX5CGLAXOSM.CAP. MTN 05/25
2.56%0100.22%4.00%2025-06-16750 M EUR1,000.00 EUR1,000.00 EURGlaxoSmithKline Capital Plc
XXS255381768GSK CAP B.V. 22/27 MTN
2.35%0101.59%3.00%2027-11-28500 M EUR1,000.00 EUR100,000.00 EURGSK Capital BV
XXS182282812GLAXOSM.CAP. MTN 18/26MTN
2.21%098.99%1.25%2026-05-211 B EUR1,000.00 EUR100,000.00 EURGlaxoSmithKline Capital Plc
GGX5BGLAXOSM.CAP. MTN 17/26
2.04%098.60%1.00%2026-09-12700 M EUR1,000.00 EUR100,000.00 EURGlaxoSmithKline Capital Plc
117RNGLAXOSMITHKLINE CAPITAL PLC 3.375% GTD SNR EMTN 20/12/20270.84%0112.19%3.38%2027-12-20307.77 M GBP1,000.00 GBP100,000.00 GBPGlaxoSmithKline Capital Plc
AAQ72GLAXOSMITHKLINE CAPITAL PLC 0.883% GTD SNR EMTN 21/09/200.88%2028-09-2142.5 B JPY100,000,000.00 JPY100,000,000.00 JPYGlaxoSmithKline Capital Plc